Cart
sales@molnova.com
2,4-Dihydroxy-4,6-dimethoxydihydrochalcone
CAS No. 75679-58-2
2,4-Dihydroxy-4,6-dimethoxydihydrochalcone( —— )
Catalog No. M31356 CAS No. 75679-58-2
2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 684 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product Name2,4-Dihydroxy-4,6-dimethoxydihydrochalcone
-
NoteResearch use only, not for human use.
-
Brief Description2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.
-
Description2,4-Dihydroxy-4,6-dimethoxydihydrochalcone is a natural product for research related to life sciences.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number75679-58-2
-
Formula Weight302.3
-
Molecular FormulaC17H18O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Licarin A
(±)-Licarin A ((±)-trans-Dehydrodiisoeugenol) is a dihydrobenzofuran neolignan, the resultant of an oxidative coupling reaction of isoeugenol and horseradish peroxidase (HRP) enzyme. (±)-Licarin A shows 100% parasites mortality at 200 μM.
-
Valbenazine
A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.
-
Nemolizumab
Nemolizumab (CIM331) is a humanized monoclonal antibody targeting the human interleukin-31 receptor A, inhibiting IL-31 binding and subsequent signal transduction. It is useful for studying atopic dermatitis with pruritus.
